NDC 50991-788

Alahist PE

Dexbrompheniramine Maleate, Phenylephrine Hydrochloride

Alahist PE is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Poly Pharmaceuticals, Inc.. The primary component is Dexbrompheniramine Maleate; Phenylephrine Hydrochloride.

Product ID50991-788_ada2d582-5814-2029-e053-2a95a90ae567
NDC50991-788
Product TypeHuman Otc Drug
Proprietary NameAlahist PE
Generic NameDexbrompheniramine Maleate, Phenylephrine Hydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-08-24
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NamePoly Pharmaceuticals, Inc.
Substance NameDEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
Active Ingredient Strength2 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 50991-788-02

12 TABLET in 1 BLISTER PACK (50991-788-02)
Marketing Start Date2020-08-24
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.